Ridwan, Febriza A, Linggi EB, Natzir R, Tazlim NA. Correlation between blood pressure and obesity parameter against cystatin-C and adiponectin levels in serum of obese adolescent. Mol Cell Biomed Sci. 2020; 4 (3): 105-12, CrossRef.

Kovesdy CP, Furth S, Zoccali C, World Kidney Day Steering Committee. Obesity and kidney disease: Hidden consequences of the epidemic. Indian J Nephrol. 2017; 27(2): 85-92, CrossRef.

Lukito AA, Bakri S, Kabo P, Wijaya A. The mechanism of coronary artery calcification in centrally obese non-diabetic men: Study on the interaction of leptin, free leptin index, adiponectin, hs-C reactive protein, bone morphogenetic protein-2 and matrix gla protein. Mol Cell Biomed Sci. 2020; 4(3): 88-93, CrossRef.

Hill AA, Anderson-Baucum EK, Kennedy AJ, Webb CD, Yull FE, Hasty AH. Activation of NF-κB drives the enhanced survival of adipose tissue macrophages in an obesogenic environment. Mol Metab. 2015; 4(10): 665-77, CrossRef.

Olszanecka-Glinianowicz M, Zahorska-Markiewicz B, Janowska J, Zurakowski A. Serum concentrations of nitric oxide, tumor necrosis factor (TNF)-alpha and TNF soluble receptors in women with overweight and obesity. Metabolism. 2004; 53: 1268-73, CrossRef.

Fujita K, Wada K, Nozaki Y, Yoneda M, Endo H, Takahashi H, et al. Serum nitric oxide metabolite as a biomarker of visceral fat accumulation: clinical significance of measurement for nitrate/nitrite. Med Sci Monit. 2011; 17(3): CR123-31, CrossRef.

Chang TJ, Zheng CM, Wu MY, Chen TT, Wu YC, Wu YL, et al. Relationship between body mass index and renal function deterioration among the Taiwanese chronic kidney disease population. Sci Rep. 2018; 8(1): 6908, CrossRef.

Foroumandi E, Alizadeh M, Kheirouri S, Asghari Jafarabadi M. Exploring the role of body mass index in the relationship of serum nitric oxide and advanced glycation end products in apparently healthy subjects. PLoS One. 2019; 14(3): e0213307, CrossRef.

Noronha BT, Li JM, Wheatcroft SB, Shah AM, Kearney MT. Inducible nitric oxide synthase has divergent effects on vascular and metabolic function in obesity. Diabetes. 2005; 54(4): 1082-9, CrossRef.

Friedenreich CM, Ryder-Burbidge C, McNeil J. Physical activity, obesity and sedentary behavior in cancer etiology: Epidemiologic evidence and biologic mechanisms. Mol Oncol. 2021; 15: 790-800, CrossRef.

Grant SJ, Chang DH, Liu J, Wong V, Kiat H, Bensoussan A. Chinese herbal medicine for impaired glucose tolerance: A randomized placebo-controlled trial. BMC Complement Altern Med. 2013; 13: 104, CrossRef.

Wu YS, Ho SY, Nan FH, Chen SN. Ganoderma lucidum beta 1,3/1,6 glucan as an immunomodulator in inflammation induced by a high-cholesterol diet. BMC Complement Altern Med. 2016; 16: 500, CrossRef.

Klupp NL, Kiat H, Bensoussan A, Steiner GZ, Chang DH. A double-blind, randomized, placebo-controlled trial of Ganoderma lucidum for the treatment of cardiovascular risk factors of metabolic syndrome. Sci Rep. 2016; 6: 29540, CrossRef.

Chan SW, Tomlinson B, Chan P, Lam CWK. The beneficial effects of Ganoderma lucidum on cardiovascular and metabolic disease risk. Pharm Biol. 2021; 59(1): 1159-69, CrossRef.

Sugita P, Sargowo D. Beta-1,3/1,6-D-glucan chemical structure characterization of Indonesian Ganoderma lucidum mycelium extract. Arterioscler Thromb Vasc Biol. 2019; 39: A366, article.

Heriansyah T, Nurwidyaningtyas W, Sargowo D, Tjahjono CT, Wihastuti TA. Polysaccharide peptide (PSP) Ganoderma lucidum: A potential inducer for vascular repair in type 2 diabetes mellitus model. Vasc Health Risk Manag. 2019; 15: 419-27, CrossRef.

Meenakshi SR, Agarwal R. Nitric oxide levels in patients with chronic renal disease. J Clin Diagn Res. 2013; 7(7): 1288-90, CrossRef.

Marpaung RDH, Ganie RA, Nasution AT. The difference between nitric oxide (NO) and serum creatinine (SC) levels in hemodialyzed and non-hemodialyzed chronic kidney disease patients at H. Adam Malik Hospital, Medan, Indonesia. IJBS. 2019; 13(1): 22-5, CrossRef.

Sena CM, Leandro A, Azul L, Seiça R, Perry G. Vascular oxidative stress: Impact and therapeutic approaches. Front Physiol. 2018; 9: 1668, CrossRef.

Steven S, Frenis K, Oelze M, Kalinovic S, Kuntic M, Bayo Jimenez MT, et al. Vascular inflammation and oxidative stress: Major triggers for cardiovascular disease. Oxid Med Cell Longev. 2019; 2019: 7092151, CrossRef.

Sartika CR, Wijaya A, As’ad S. Pro-inflammatory profiles of Indonesian adult men with central obesity: a preliminary study on TNF-alpha, STNFR-2 and IL-1beta. Indones Biomed J. 2010; 2(1): 66-72, CrossRef.

Harefa EF, Patellongi I, and Kurniawati M. Association between cathepsin S, cystatin C and high sensitivity C-Reactive protein (HsCRP) with oxidized LDL (Ox-LDL) in men with central obesity. Indones Biomed J. 2012; 4(1): 50-7, CrossRef.

Kalantar-Zadeh K, Rhee CM, Chou J, Ahmadi SF, Park J, Chen JL, et al. The obesity paradox in kidney disease: how to reconcile it with obesity management. Kidney Int Rep. 2017; 2(2): 271-81, CrossRef.

Chang AR, Zafar W, Grams ME. Kidney function in obesity-challenges in indexing and estimation. Adv Chronic Kidney Dis. 2018; 25(1): 31-40, CrossRef.

Koch VH. Obesity facts and their influence on renal function across the life span. Front Med (Lausanne). 2021; 8: 704409, CrossRef.

Sargowo D, Wihastuti TA, Sukotjo CT, Anjani PM, Handayani O, Adrian LH. The effect of polysaccharides peptides Ganoderma lucidum to aortic foam cell count and lipid profile in type 2 diabetic model Rattus norvegicus strain Wistar. Indones Biomed J. 2017; 9: 153-9, CrossRef.

Hassan HM, Mahran YF, & Ghanim A. Ganoderma lucidum ameliorates the diabetic nephropathy via down-regulatory effect on TGFβ-1 and TLR-4/NFκB signalling pathways. The Journal of pharmacy and pharmacology. 2021; 73: 1250-61, CrossRef.

Carlström M. Nitric oxide signalling in kidney regulation and cardiometabolic health. Nat Rev Nephrol. 2021; 17: 575-90, CrossRef.

Lan Q, Zheng L, Zhou X, Wu H, Buys N, Liu Z, et al. The value of blood urea nitrogen in the prediction of risks of cardiovascular disease in an older population. Front Cardiovasc Med. 2021; 8: 614117, CrossRef.

Smith GL, Shlipak MG, Havranek EP, Foody JM, Masoudi FA, Rathore SS, et al. Serum urea nitrogen, creatinine, and estimators of renal function: Mortality in older patients with cardiovascular disease. Arch Intern Med. 2006; 166(10): 1134-42, CrossRef.

Du C, Guan Q, Diao H, Yin Z, Jevnikar AM. Nitric oxide induces apoptosis in renal tubular epithelial cells through activation of caspase-8. Am J Physiol Renal Physiol. 2006; 290(5): F1044-54, CrossRef.

Zhu Y, Cui H, Xia Y, Gan H. RIPK3-mediated necroptosis and apoptosis contributes to renal tubular cell progressive loss and chronic kidney disease progression in rats. PLoS One. 2016; 11(6): e0156729, CrossRef.

Yuniarty D, Santoso A, Arif M. Correlation of neopterin and TNF-alpha with asymmetric dimethylarginine in metabolic syndrome. Indones Biomed J. 2011; 3(3): 200-3, CrossRef.

Gounden V, Bhatt H, Jialal I. Renal Function Tests. Treasure Island: StatPearls Publishing; 2022, NLMID.

Carvounis CP, Nisar S, Guro-Razuman S. Significance of the fractional excretion of urea in the differential diagnosis of acute renal failure. Kidney Int. 2002; 62(6): 2223-9, CrossRef.

Nogi K, Kawakami R, Ueda T, Nogi M, Ishihara S, Nakada Y, et al. Prognostic value of fractional excretion of urea nitrogen at discharge in acute decompensated heart failure. J Am Heart Assoc. 2021; 10(16): e020480, CrossRef.

Robinson PG, Newman D, Reitz CL, Vaynberg LZ, Bahga DK, Levitt MH. A large drawing of a nephron for teaching medical students renal physiology, histology, and pharmacology. Adv Physiol Educ. 2018; 42(2): 192-9, CrossRef.

Ciardullo S, Ballabeni C, Trevisan R, Perseghin G. Metabolic syndrome, and not obesity, is associated with chronic kidney disease. Am J Nephrol. 2021; 52(8): 666-72, CrossRef.

Lemieux I, Després JP. Metabolic syndrome: Past, present and future. Nutrients. 2020; 12(11): 3501, CrossRef.

Swiatkiewicz I, Wozniak A, Taub PR. Time-restricted eating and metabolic syndrome: current status and future perspectives. Nutrients. 2021; 13(1): 221, CrossRef.